Immunology·animal evidence
Aged immune systems reveal another possible inflammaging pathway
Researchers report that cytotoxic CD4+ T cells can promote age-associated myelopoiesis through CCL5–CCR5 signaling, with a CCR5 antagonist rebalancing immunity in aged mice.
AgeBeacon editorial summary · Source publication:
Why it matters
The work connects immune-cell changes with age-related inflammatory blood production and points to a druggable pathway.
Beacon take
Mechanistically promising, but the therapeutic result described here is preclinical. Human longevity benefit is unproven.
Read the source
This is an AgeBeacon interpretation of research published elsewhere. Check the original paper or record for methods, results and limitations.
Nature Aging · Research briefingEducational information, not medical advice. Evidence categories describe the research cited, not a recommendation to use a treatment.
← All research briefs